Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice

Fig. 6

Biodistribution of BER and CUR to each organ after orally administration of BER  +  CUR, LBC, LSDBC and DEAE-DEX@LSDBC at a BER dose of 45 mg/kg for A 1 h, C 6 h and E 24 h and at a CUR dose of 15 mg/kg for B 1 h, D 6 h and F 24 h. Each bar represents the mean  ±  SD (n  =  3). *p  <  0.05, **p  <  0.01 and ***p  <  0.001 vs DEAE-DEX@LSDBC

Back to article page